The iconic rise of Viagra presented a considerable chance for investors , but its patent has expired , creating a intricate landscape. Off-brand versions have entered the space , diminishing profits and putting a strain on profit percentages . While major drug companies maintain a presence in this area, the potential looks unclear by ongoing rivalr